SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
A new report from ProPublica and the New York Times about insurers and opioid addiction reveals insurance providers prioritize drug costs over addiction risks. (Photo: frankieleon/Flickr/cc)
Bolstering Single-Payer Case, Report Shows How For-Profit Insurers Fuel Opioid Crisis
"In case you didn't know, the opioid epidemic is fueled in part by systemic failures in healthcare."
Sep 18, 2017
Showcasing yet another downside of the nation's for-profit system, a new report by ProPublica and the New York Times reveals that despite the U.S. opioid crisis, many insurance companies provide easy access to highly addictive opioid medications for pain relief while restricting access to less-risky but more costly alternatives.
As the nation's opioid epidemic has grown, "drugmakers, pharmaceutical distributors, pharmacies, and doctors have come under intense scrutiny in recent years, but the role that insurers--and the pharmacy benefit managers that run their drug plans--have played in the opioid crisis has received less attention," note the Times' Katie Thomas and ProPublica's Charles Ornstein.
The pair spoke with patients who have struggled to access pain relief medications through insurance providers such as Anthem and UnitedHealthcare, the nation's largest insurer. They also analyzed Medicare prescription drug plans that covered 35.7 million Americans and found only a third of those with coverage could access "a painkilling skin patch that contains a less-risky opioid," whereas nearly all plans covered "common opioids, and very few required any prior approval." Further, they found that "insurers have also erected more hurdles to approving addiction treatments than for the addictive substances themselves."
And although addiction experts have observed that as this epidemic evolves, "the problem now appears to be rooted more in the illicit trade of heroin and fentanyl," the reporters also note a recent Centers for Disease Control and Prevention analysis showing that "risks for chronic use" increase "with each additional day" an opioid is prescribed, and of those patients who receive initial 10-day prescriptions, 20 percent will continue using the drugs after one year.
The ProPublica/Times report provoked an outpouring of personal anecdotes that often mirrored those featured in the article, and strong condemnation of insurance companies, as well as doctors and the pharmaceutical industry.
It also spurred calls for reform--to prescription practices and drug costs, but also to healthcare more broadly.
This report comes less than a week after Sen. Bernie Sanders (I-Vt.), with substantial support from Senate Democrats, introduced a bill aimed at reforming how Americans access health insurance and healthcare. Sanders' Medicare for All bill proposes transitioning from the U.S.'s for-profit healthcare system toward a national single-payer program that guarantees care for all Americans.
In an op-ed for the Boston Globe last week, Sen. Elizabeth Warren (D-Mass.) wrote of the opioid crisis: "I believe we can beat this epidemic," while also noting that overcoming the nationwide opioid crisis requires coordination and investment at all levels. Warren--who is co-sponsoring Sanders' healthcare bill-- added:
Healthcare and social workers, counselors, and law enforcement agencies, and policy makers and administrators at the local, state, and federal levels of government are already putting it all on the line to help people overcome addiction. We must give them with the tools and support they need so we can win this fight.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Showcasing yet another downside of the nation's for-profit system, a new report by ProPublica and the New York Times reveals that despite the U.S. opioid crisis, many insurance companies provide easy access to highly addictive opioid medications for pain relief while restricting access to less-risky but more costly alternatives.
As the nation's opioid epidemic has grown, "drugmakers, pharmaceutical distributors, pharmacies, and doctors have come under intense scrutiny in recent years, but the role that insurers--and the pharmacy benefit managers that run their drug plans--have played in the opioid crisis has received less attention," note the Times' Katie Thomas and ProPublica's Charles Ornstein.
The pair spoke with patients who have struggled to access pain relief medications through insurance providers such as Anthem and UnitedHealthcare, the nation's largest insurer. They also analyzed Medicare prescription drug plans that covered 35.7 million Americans and found only a third of those with coverage could access "a painkilling skin patch that contains a less-risky opioid," whereas nearly all plans covered "common opioids, and very few required any prior approval." Further, they found that "insurers have also erected more hurdles to approving addiction treatments than for the addictive substances themselves."
And although addiction experts have observed that as this epidemic evolves, "the problem now appears to be rooted more in the illicit trade of heroin and fentanyl," the reporters also note a recent Centers for Disease Control and Prevention analysis showing that "risks for chronic use" increase "with each additional day" an opioid is prescribed, and of those patients who receive initial 10-day prescriptions, 20 percent will continue using the drugs after one year.
The ProPublica/Times report provoked an outpouring of personal anecdotes that often mirrored those featured in the article, and strong condemnation of insurance companies, as well as doctors and the pharmaceutical industry.
It also spurred calls for reform--to prescription practices and drug costs, but also to healthcare more broadly.
This report comes less than a week after Sen. Bernie Sanders (I-Vt.), with substantial support from Senate Democrats, introduced a bill aimed at reforming how Americans access health insurance and healthcare. Sanders' Medicare for All bill proposes transitioning from the U.S.'s for-profit healthcare system toward a national single-payer program that guarantees care for all Americans.
In an op-ed for the Boston Globe last week, Sen. Elizabeth Warren (D-Mass.) wrote of the opioid crisis: "I believe we can beat this epidemic," while also noting that overcoming the nationwide opioid crisis requires coordination and investment at all levels. Warren--who is co-sponsoring Sanders' healthcare bill-- added:
Healthcare and social workers, counselors, and law enforcement agencies, and policy makers and administrators at the local, state, and federal levels of government are already putting it all on the line to help people overcome addiction. We must give them with the tools and support they need so we can win this fight.
Showcasing yet another downside of the nation's for-profit system, a new report by ProPublica and the New York Times reveals that despite the U.S. opioid crisis, many insurance companies provide easy access to highly addictive opioid medications for pain relief while restricting access to less-risky but more costly alternatives.
As the nation's opioid epidemic has grown, "drugmakers, pharmaceutical distributors, pharmacies, and doctors have come under intense scrutiny in recent years, but the role that insurers--and the pharmacy benefit managers that run their drug plans--have played in the opioid crisis has received less attention," note the Times' Katie Thomas and ProPublica's Charles Ornstein.
The pair spoke with patients who have struggled to access pain relief medications through insurance providers such as Anthem and UnitedHealthcare, the nation's largest insurer. They also analyzed Medicare prescription drug plans that covered 35.7 million Americans and found only a third of those with coverage could access "a painkilling skin patch that contains a less-risky opioid," whereas nearly all plans covered "common opioids, and very few required any prior approval." Further, they found that "insurers have also erected more hurdles to approving addiction treatments than for the addictive substances themselves."
And although addiction experts have observed that as this epidemic evolves, "the problem now appears to be rooted more in the illicit trade of heroin and fentanyl," the reporters also note a recent Centers for Disease Control and Prevention analysis showing that "risks for chronic use" increase "with each additional day" an opioid is prescribed, and of those patients who receive initial 10-day prescriptions, 20 percent will continue using the drugs after one year.
The ProPublica/Times report provoked an outpouring of personal anecdotes that often mirrored those featured in the article, and strong condemnation of insurance companies, as well as doctors and the pharmaceutical industry.
It also spurred calls for reform--to prescription practices and drug costs, but also to healthcare more broadly.
This report comes less than a week after Sen. Bernie Sanders (I-Vt.), with substantial support from Senate Democrats, introduced a bill aimed at reforming how Americans access health insurance and healthcare. Sanders' Medicare for All bill proposes transitioning from the U.S.'s for-profit healthcare system toward a national single-payer program that guarantees care for all Americans.
In an op-ed for the Boston Globe last week, Sen. Elizabeth Warren (D-Mass.) wrote of the opioid crisis: "I believe we can beat this epidemic," while also noting that overcoming the nationwide opioid crisis requires coordination and investment at all levels. Warren--who is co-sponsoring Sanders' healthcare bill-- added:
Healthcare and social workers, counselors, and law enforcement agencies, and policy makers and administrators at the local, state, and federal levels of government are already putting it all on the line to help people overcome addiction. We must give them with the tools and support they need so we can win this fight.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.